Showing results (161-170 of 193) with videos related to
Sort By:
Pageof 20
Communications Medicine|May 23, 2022
Personalised therapeutic management of epileptic patients guided by pathway-driven breath metabolomicsKapil Dev Singh, Martin Osswald, Victoria C Ziesenitz, et al.British Journal of Clinical Pharmacology|March 18, 2006
Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individualsChristiane Hesse, Steffen P Luntz, Heike Siedler, et al.Drugs & Aging|January 13, 2023
Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory StudyAnnette Eidam, Julian Marji, Petra Benzinger, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 19, 2019
Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal filmKlara Kiene, Noriyuki Hayasi, Jürgen Burhenne, et al.Trials|July 1, 2020
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trialFelicitas Stoll, Antje Blank, Gerd Mikus, et al.Clinical Pharmacokinetics|November 21, 2019
Midazolam Pharmacokinetics in Obese and Non-obese Children and AdolescentsChristina Gade, Eva Sverrisdóttir, Kim Dalhoff, et al.Clinical and Translational Science|March 17, 2022
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyMichael Boettcher, Gerd Mikus, Dietmar Trenk, et al.Clinical Pharmacokinetics|December 20, 2019
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug InteractionsXia Li, Sebastian Frechen, Daniel Moj, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trialThomas Schmitt, Hartmut Goldschmidt, Kai Neben, et al.Therapeutic Advances in Psychopharmacology|December 5, 2017
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive natureAndreas D Meid, Irene Bighelli, Sarah Mächler, et al.Pageof 20